Whether through illness or injury, 36 million people suffer from blindness worldwide, and until just a decade ago those afflicted had little chance of regaining their sight. In 2009, doctors at the ...
The study was conducted according to the principles of good practice for decision analytic modeling according to the International Society for Pharmacoeconomics and Outcome Research (ISPOR) task force ...
On Friday September 28, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the outweighs the risks to health, an important ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
Argus II is a novel healthcare technology that restores vision in RP patients. Improvements in visual acuity are expected to lead to improvements in patient self-confidence, decreasing their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback